Acquired dysfibrinogenemia secondary to multiple myeloma

43Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Abnormal coagulation properties indicative of a dysfibrinogen were found in the plasma of a 72-year-old male with multiple myeloma (IgGκ, stage IIIA). The patient had high paraprotein concentration (85.75 g/l) and prolonged thrombin time (76.8 s), activated partial thromboplastin time (39.5 s), prothrombin time (23.5 s) and reptilase time (72.0 s). The fibrinogen level was increased. The fibrin polymerization induced by both thrombin and reptilase was impaired. Scanning electron microscopy revealed abnormal clot morphology. After six months of treatment, the paraprotein level decreased (19.48 g/l) and coagulation normalized as well as fibrin polymerization and fibrin clot morphology. It was found that the paraprotein interacts with the γ-chain of fibrinogen. Acquired dysfibrinogenemia associated with multiple myeloma was diagnosed in the 72-year-old patient. Copyright © 2008 S. Karger AG.

Cite

CITATION STYLE

APA

Kotlín, R., Sobotková, A., Riedel, T., Salaj, P., Suttnar, J., Reicheltová, Z., … Dyr, J. E. (2008). Acquired dysfibrinogenemia secondary to multiple myeloma. Acta Haematologica, 120(2), 75–81. https://doi.org/10.1159/000160182

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free